The MPP technology enhances drug delivery by modifying the surface properties of nanoparticles. These particles are engineered to be small and hydrophilic, allowing them to evade entrapment by the mucin fibers in mucus. By preventing adhesion to mucus, the drug-loaded nanoparticles can travel deeper into tissues, ensuring a higher concentration of the therapeutic agent reaches the target site. This increases the drug's bioavailability and efficacy, particularly in conditions affecting the ocular surface.
